Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE)
Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times (ESCAPE) Trial
Sponsor: Heart and Stroke Foundation of Canada
Terminated
On DSMB advice, trial recruitment has been halted for efficacy. F/U continues.
Other terminated trials from Heart and Stroke Foundation of Canada
- CVA (Cerebrovascular Accident) · Phase NA · May 2025
- Coronary Artery Disease · Phase PHASE3 · Feb 2009
See all terminations from Heart and Stroke Foundation of Canada
Other Ischemic Stroke trials with similar outcome
A PHASE3 clinical study on Ischemic Stroke, this trial is terminated or withdrawn. The trial is conducted by Heart and Stroke Foundation of Canada and has accumulated 5 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE3
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Heart and Stroke Foundation of Canada
- Hotchkiss Brain Institute, University of Calgary
- Medtronic - MITG
- University of Calgary
For direct contact, visit the study record on ClinicalTrials.gov .